| Dr Justin Liggett, DDS | |
|
765 Morning Star Dr, Sonora, CA 95370-5193 | |
| (209) 532-7418 | |
| (209) 533-3515 |
| Full Name | Dr Justin Liggett |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 765 Morning Star Dr, Sonora, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184090201 | NPI | - | NPPES |
| 05652653 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | D13543 (Minnesota) | Secondary |
| 122300000X | Dentist | 060300 (New York) | Secondary |
| 122300000X | Dentist | 105682 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Liggett, DDS 765 Morning Star Dr, Sonora, CA 95370-5193 Ph: (209) 532-7418 | Dr Justin Liggett, DDS 765 Morning Star Dr, Sonora, CA 95370-5193 Ph: (209) 532-7418 |
News Archive
An international collaboration of researchers are advancing precision medicine to men with advanced prostate cancer.
Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, hypertension, and abnormal cholesterol levels, compared to participants who did not have the surgery, according to a study in the September 19 issue of JAMA, and theme issue on obesity.
The $463 billion spending resolution (HJ Res 20) for fiscal year 2007 passed last week by the House contains a provision that cancels funding for a program aimed at supporting state-level efforts to provide HIV prevention, early diagnosis, and counseling services to pregnant women and infants, CongressDaily reports.
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) announced overall survival (OS) for tivozanib, an investigational agent, from the Phase 3 TIVO-1 (TIvozanib Versus sOrafenib in 1st line advanced RCC) study in patients with advanced renal cell carcinoma (RCC). The final OS analysis, as specified by the protocol, shows a median OS of 28.8 months (95% confidence interval [CI]: 22.5–NA) for tivozanib versus a median OS of 29.3 months (95% CI: 29.3–NA) for the comparator arm, sorafenib.
Some veteran Democratic lawmakers are being called to the carpet as a result of the difficulties with healthcare.gov and news of health policy cancellations. Meanwhile, also in the news, New Jersey Gov. Chris Christie also offers a bleak prediction of the health law's future.
› Verified 1 days ago
Wayne Alan Mathe, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 101 Hospital Rd, Sonora, CA 95370 Phone: 209-533-7213 | |
Dr. Scott Carl Henning, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 14570 Mono Way, Suite I, Sonora, CA 95370 Phone: 209-536-1954 Fax: 209-536-6554 | |
Paul J Berger, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 13919 Mono Way, Sonora, CA 95370 Phone: 209-533-9630 Fax: 209-536-6044 | |
Patricia Rivas, DDS Dentist Medicare: Medicare Enrolled Practice Location: 13975 Mono Way Ste I, Sonora, CA 95370 Phone: 209-533-9603 Fax: 209-533-9604 | |
Dr. Robyn Alison Ritchie, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 193 Fairview Ln Ste J, Sonora, CA 95370 Phone: 209-754-3816 | |
Dr. David E. Woodhams, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 13945 Mono Way, Suite A, Sonora, CA 95370 Phone: 209-532-0808 Fax: 209-532-1331 |